NHS England South West - Diabetic Eye Screening Programmes for Cornwall, Devon, Somerset, Gloucestershire and Bristol, North Somerset, South Gloucestershire (BNSSG)

Descriptions

NHSE South West (The Commissioner) sought to re-commission five Diabetic Eye Screening Programmes (DESP) to deliver screening to the eligible populations of Cornwall and Isles of Scilly (Lot 1), Devon (Lot 2), Somerset (Lot 3), Gloucestershire (Lot 4), and BNSSG (Lot 5). Adverts were placed on Contracts Finder and the Find a Tender Service and an Invitation to Tender (ITT) process, based on the Open procedure, was undertaken during summer / autumn 2023 to identify the Most Economically Advantageous Tender and therefore determine the incoming provider for each Lot. The eligible population includes patients over the age of 12 diagnosed with diabetes and registered with, or eligible to be registered with, a GP in the lot area as well as individuals within prisons, secure units and the armed forces. The aim of the DESP is to reduce the risk of sight loss amongst people with diabetes by the prompt identification and effective treatment, if necessary, of sight threatening diabetic retinopathy. This will be achieved by delivering an evidence-based service that: •Identifies the eligible population and ensures effective delivery with maximum coverage •Is safe, effective, high quality, externally and independently monitored, and quality assured •Leads to earlier detection, appropriate referral, effective treatment and improved outcomes •Is delivered and supported by suitably trained, competent and qualified clinical and non-clinical staff who, where relevant, participate in recognised ongoing continuing medical education (CME), continuous professional development (CPD) and quality assurance (QA) schemes •Has audit embedded in the service •Works effectively with other stakeholders to ensure the care pathway is smooth and efficient There are 3 key elements of service delivery, namely: •Call/recall for all people with diabetes invited for routine digital screening; this is currently undertaken on an annual basis, but screening intervals are likely to extend to 2 years for people at low risk during the contract term, in line with national guidance •Digital surveillance where individuals need more frequent screening •Slit lamp bio-microscopy (SLB) for those individuals where normal photography is inappropriate (e.g. those having cataracts). Optical Coherence Tomography (OCT) does not form part of these Contracts at this time, though this position may change over the life of the contract in line with national guidance. Contracts have been awarded as follows for a term of 6 years, with an option to extend for a further 3 years at the sole discretion of the Commissioner: •Lot 1: Royal Cornwall Hospitals NHS Trust •Lot 2: InHealth Intelligence Ltd •Lot 3: Somerset NHS Foundation Trust •Lot 4: Gloucestershire Hospitals NHS Foundation Trust •Lot 5: InHealth Intelligence Ltd The Contracts are due to commence on 1st April 2024.